U.S. Professional Services Stock News

In April 2026, Dynex Capital, Inc. announced a new share repurchase program authorizing the buyback of up to US$300 million of its stock, effective through April 30, 2028, while concurrently allowing a prior plan to expire. The move signals the Board’s willingness to deploy substantial capital into equity repurchases even as the company recently reported a quarterly net loss of US$80.36 million, or US$0.41 per basic and diluted share from continuing operations. Against this backdrop, we...

Galaxy Digital Inc. has reported first-quarter 2026 results, with sales of US$10.04 billion, revenue of US$10.21 billion, and a net loss of US$216.31 million, all lower than the same period a year earlier as softer digital-asset markets weighed on performance. At the same time, the company is accelerating a shift toward AI-focused data centers and B2B financial infrastructure, aiming to diversify away from pure crypto trading by expanding its Helios multi-tenant facilities and institutional...

If you are wondering whether On Holding's current share price reflects its true value, this breakdown will help you line up the story the numbers are telling. The stock recently closed at US$34.54, with returns of 4.7% decline over the past week, 0.7% decline over the past month, and 26.4% decline year to date, while the 1-year return sits at 29.4% decline and the 3-year return at 1.9%. Recent coverage has focused on how the stock's pullback contrasts with its longer term performance,...

Corporación América Airports (CAAP) released operating figures for March 2026 and the year to date, showing higher passenger traffic, cargo volumes, and aircraft movements compared with the prior year, giving investors fresh data on its airport network activity. See our latest analysis for Corporación América Airports. Despite the stronger traffic figures, the recent share price has pulled back, with a 30 day share price return of 6.18% and a 90 day share price return of 18.05%. However, the...

EMCOR Group (EME) is back in focus after reporting record first quarter 2026 results, with US$4.63b in sales and US$305.48m in net income, and lifting full year revenue and earnings guidance. See our latest analysis for EMCOR Group. The earnings beat and higher full year guidance have coincided with a sharp re rating, with EMCOR’s 30 day share price return of 18.95% adding to a very large 5 year total shareholder return. If you are curious what other companies are benefiting from similar...

In April 2026, AeroVironment unveiled Halo_Shield, a modular, tile-based counter-unmanned aircraft system and highlighted successful shipboard tests of its LOCUST laser weapon system, while the U.S. Army awarded the company a US$14.6 million production contract for its VAPOR CLE unmanned aircraft system. This combination of a new layered C-UAS architecture, proven directed-energy performance at sea, and fresh U.S. Army funding highlights AeroVironment’s expanding role across air, land, and...

CF Industries Holdings, Inc. recently declared a US$0.50 per-share quarterly dividend on its common stock, payable on May 29, 2026, to shareholders of record as of May 15, 2026, alongside shareholder approval of all director nominees, say-on-pay, and auditor ratification. Management highlighted strong 2025 operating achievements, including 10.10 million tons of ammonia production, record low safety incidents, US$1.70 billion returned to shareholders, and progress on low-carbon ammonia and...

Wondering whether MercadoLibre at around US$1,850 per share still offers value, or if the best days of the stock are behind it? This article walks through the numbers so you can judge for yourself. The share price has moved by 0.8% over the last 7 days and 7.6% over the last 30 days, while the year to date return is a 6.3% decline and the 1 year return is an 18.9% decline, set against a 3 year return of 48.8% and a 5 year return of 24.9%. Recent headlines around MercadoLibre have focused on...

Melco Resorts & Entertainment (NasdaqGS:MLCO) heads into its Q1 2026 update with recent quarterly numbers that put revenue at about US$1.3b in Q4 2025 and basic EPS at US$0.16. This caps off a year where trailing twelve month EPS reached US$0.46 on revenue of roughly US$5.2b. Over the past few quarters, the company has seen revenue range between US$1.2b and US$1.3b per quarter, while basic EPS moved from US$0.08 in Q1 2025 to US$0.19 in Q3 before landing at US$0.16 in Q4. This result comes...

Ares Management (NYSE:ARES) has appointed Peter Ogilvie as Chief Operating Officer and Head of Strategy. Ogilvie is tasked with driving global growth initiatives across the firm’s platform. The move reflects a leadership shift that could influence how Ares pursues expansion and integration of future acquisitions. Ares Management, trading at $119.0, has mixed recent performance, with a 3.3% return over the past week and 12.5% over the past month, set against a 28.5% decline year to date and...

Q2 Holdings (NYSE:QTWO) has introduced new AI driven fraud prevention tools focused on continuous account takeover protection. The company has also rolled out Q2 Treasury Fulfillment, a solution aimed at streamlining and automating treasury onboarding for commercial clients. Both features expand Q2's digital banking platform beyond its recent earnings updates, targeting fraud risk and onboarding friction for financial institutions. Q2 Holdings enters this product update cycle with its...

Halozyme Therapeutics (NasdaqGS:HALO) has appointed Darren Snellgrove as Chief Financial Officer. Snellgrove is described as a seasoned financial executive with extensive biopharmaceutical experience. The CFO appointment represents a key leadership change that may influence future capital allocation and corporate priorities. For investors following biopharma platforms, Halozyme Therapeutics focuses on drug delivery technologies and partnerships with larger pharmaceutical companies. A CFO...

Royal Caribbean Cruises Ltd. reported past first‑quarter 2026 results with revenue of US$4,452 million and net income of US$941 million, lifting diluted EPS from continuing operations to US$3.48 from US$2.70 a year earlier. Alongside the earnings beat, the company confirmed orders for sixth and seventh Icon Class ships and updated full‑year adjusted EPS guidance to US$17.10–US$17.50, tying near‑term performance to a multi‑year fleet expansion and product investment plan. With first‑quarter...

Citi (NYSE:C) launched Sky, an AI enabled virtual adviser for wealth management, built with Google Cloud and DeepMind. The bank introduced Arc, a platform for deploying AI agents across its business to automate complex internal tasks. Citi was recognized as a Leader in Digital Asset Adoption at an institutional awards event, reflecting progress in tokenized payments and programmable finance. For investors tracking how large banks use technology, Citi is expanding its use of AI and digital...

Investors may be wondering whether Indivior Pharmaceuticals at US$37.66 still offers value after a strong run, or if most of the opportunity is already priced in. The stock has returned 13.3% over the last 7 days, 22.9% over 30 days, 5.4% year to date, 214.4% over 1 year, 88.0% over 3 years and 250.3% over 5 years. This raises questions about how its current price lines up with underlying value. Recent coverage has focused on Indivior Pharmaceuticals as a US-listed pharmaceuticals business...

Caterpillar has caught the eye of many investors lately, and if you are wondering whether the current share price offers good value, the numbers provide a useful starting point. At a last close of US$889.67, the stock has delivered returns of 7.1% over 7 days, 21.8% over 30 days, 48.7% year to date, 177.8% over 1 year, 332.8% over 3 years and 303.7% over 5 years. That naturally raises questions about how much of the story is already reflected in the price. Recent headlines around Caterpillar...

If you are trying to work out whether State Street's current share price reflects its real worth, the recent trading history gives you a lot to think about. The stock last closed at US$152.00, with returns of 0.8% over 7 days, 18.5% over 30 days, 17.8% year to date, 72.6% over 1 year, 144.9% over 3 years and 104.4% over 5 years. These moves have sharpened interest in how the market is pricing the bank's role in global custody and asset servicing, as well as its exposure to broader capital...

In late April 2026, Merck reported stronger-than-expected first-quarter results, raised its full-year revenue and earnings guidance, and secured FDA approval for IDVYNSO, a complete two-drug HIV-1 regimen for virologically suppressed adults. Together with advancing oncology programs such as KEYTRUDA-based regimens and WELIREG in renal cell carcinoma, these developments reinforce Merck’s efforts to broaden growth drivers ahead of expected pressure on legacy products. We’ll now examine how...

Xenon Pharmaceuticals (XENE) is back in focus after presenting Phase 3 X-TOLE2 data for azetukalner in adults with focal onset seizures, supported by long term X-TOLE extension and real world no titration feedback. See our latest analysis for Xenon Pharmaceuticals. The latest clinical update has arrived after a strong few quarters for the stock, with a 36.87% 90 day share price return and a 46.63% 1 year total shareholder return that suggest momentum has been building around Xenon’s lead...

Tempus AI (TEM) is back in focus after TIME named it one of the 10 Most Influential Health and Life Science Companies of 2026, alongside fresh oncology partnerships and upcoming earnings and Investor Day milestones. See our latest analysis for Tempus AI. Tempus AI’s recent recognition and oncology tie ups come as the share price trades at US$55.0, with a 16.06% 30 day share price return but an 11.80% year to date share price decline and a 3.61% 1 year total shareholder return decline. This...

BrightSpring Health Services (BTSG) has entered Q1 2026 earnings season after a busy 2025, with Q4 revenue at about US$3.6b and basic EPS of US$0.24 anchoring the latest reported quarter. The company reported quarterly revenue moving from US$2.6b in Q3 2024 to US$3.6b in Q4 2025, while basic EPS shifted from a US$0.13 loss per share in Q3 2024 to a positive US$0.24. This sets up a results season where the focus is on how those headline gains relate to margins and the quality of recurring...

Arteris (AIP) shares were in focus after the company announced a new collaboration with MIPS, a GlobalFoundries company, to support physical AI computing platforms across automotive, robotics, and embedded computing markets. See our latest analysis for Arteris. The collaboration news arrives after a strong run in Arteris shares, with a 30 day share price return of 64.96% and a year to date share price return of 85.82%. The 1 year total shareholder return is 330.80% and the 3 year total...

Forum Energy Technologies (FET) opened 2026 with Q1 revenue of US$208.7 million and basic EPS of US$0.40, alongside net income excluding extra items of US$4.5 million. However, trailing 12 month figures still show a net loss of US$6.3 million and basic EPS of US$0.54 in the red. Over the past year, the company has seen quarterly revenue move from US$193.3 million in Q1 2025 to US$208.7 million in Q1 2026, with basic EPS shifting from US$0.09 to US$0.40 and net income excluding extra items...

Polaris Inc. reported past first-quarter 2026 results with sales rising to US$1,658.7 million from US$1,535.8 million, while narrowing its net loss to US$47.4 million from US$66.8 million and reducing loss per share from US$1.17 to US$0.83. The quarter also showed an 8% revenue increase, gross margin expansion despite tariff pressures, and double-digit growth in key utility and commercial powersports lines, highlighting underlying operational improvements. We’ll now examine how Polaris’s...